Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Shire News

Pharma CEOs in Davos put brave face on Trump presidency
20 Jan 2017

Pharma CEOs in Davos put brave face on Trump presidency

By Ben Hirschler DAVOS, Switzerland, Jan 20 (Reuters) - Leaders of the global pharmaceutical industry, blasted by incoming U.S. President Donald Trump...

Britain's FTSE hits record highs, extends historic winning streak
13 Jan 2017

Britain's FTSE hits record highs, extends historic winning streak

* FTSE 100 touches new record, sets 14th day of gains * Pharmaceuticals rebound after Trump scare * Housebuilders top the index * ITV buoyed by broker...

U.S. says Shire subsidiaries to pay $350 mln to settle false claims act allegations
11 Jan 2017

U.S. says Shire subsidiaries to pay $350 mln to settle false claims act allegations

WASHINGTON, Jan 11 (Reuters) - Shire PLC subsidiaries will pay $350 million to settle U.S. federal and state False Claims Act allegations related to u...

Roche's emicizumab haemophilia drug succeeds in trial
22 Dec 2016

Roche's emicizumab haemophilia drug succeeds in trial

ZURICH, Dec 22 (Reuters) - Roche Holding AG's emicizumab drug for treating haemophilia A met its primary endpoint in a phase III study, the Swiss dru...

FTSE 100 movers: Pharmaceutical stocks lead FTSE's rally
16 Dec 2016

FTSE 100 movers: Pharmaceutical stocks lead FTSE's rally

(ShareCast News) - The FTSE 100 rose 0.11% to 7,006.73 points on Friday afternoon with pharmaceutical stocks leading the way. Hikma Pharmaceuticals, S...

UPDATE 1-Britain's FTSE hits one-month high as banks and miners lead cyclical charge
7 Dec 2016

UPDATE 1-Britain's FTSE hits one-month high as banks and miners lead cyclical charge

* FTSE 100 up 1.8 pct * Banks hit 1 1/2-year high * Rio benefits from Credit Suisse upgrade * WPP falls on reported DOJ probe (Recasts, adds detail ...

Broker tips: Shire, GKN, IG Group
7 Dec 2016

Broker tips: Shire, GKN, IG Group

(ShareCast News) - UBS downgraded Shire to 'neutral' from 'buy' and cut the price target to 5,000p from 5,600p saying a tougher environment for expens...